nodes	percent_of_prediction	percent_of_DWPC	metapath
Isoprenaline—PIK3R1—obesity	0.264	0.602	CbGaD
Isoprenaline—Levonordefrin—Phenylpropanolamine—obesity	0.185	1	CrCrCtD
Isoprenaline—ADRB3—obesity	0.0954	0.217	CbGaD
Isoprenaline—ADRB2—Phenylpropanolamine—obesity	0.0749	0.504	CbGbCtD
Isoprenaline—ADRB1—Phenylpropanolamine—obesity	0.0737	0.496	CbGbCtD
Isoprenaline—ADRB1—obesity	0.0431	0.0983	CbGaD
Isoprenaline—ADRB2—obesity	0.0363	0.0827	CbGaD
Isoprenaline—ADRB3—brown adipose tissue—obesity	0.0061	0.159	CbGeAlD
Isoprenaline—MAPK1—hindbrain—obesity	0.00192	0.0502	CbGeAlD
Isoprenaline—PIK3R2—digestive system—obesity	0.00189	0.0493	CbGeAlD
Isoprenaline—PIK3R2—endocrine gland—obesity	0.00156	0.0408	CbGeAlD
Isoprenaline—PIK3R3—cardiovascular system—obesity	0.00154	0.0403	CbGeAlD
Isoprenaline—PIK3R1—adrenal cortex—obesity	0.00144	0.0378	CbGeAlD
Isoprenaline—PIK3R3—pituitary gland—obesity	0.00137	0.0357	CbGeAlD
Isoprenaline—PIK3R3—adipose tissue—obesity	0.00136	0.0356	CbGeAlD
Isoprenaline—MAPK1—islet of Langerhans—obesity	0.00124	0.0325	CbGeAlD
Isoprenaline—PIK3R3—adrenal gland—obesity	0.00122	0.0319	CbGeAlD
Isoprenaline—ADRBK1—respiratory system—obesity	0.00119	0.0311	CbGeAlD
Isoprenaline—MAPK1—respiratory system—obesity	0.00117	0.0307	CbGeAlD
Isoprenaline—PIK3R1—pituitary gland—obesity	0.00117	0.0305	CbGeAlD
Isoprenaline—PIK3R1—adipose tissue—obesity	0.00116	0.0304	CbGeAlD
Isoprenaline—Sweating—Benzphetamine—obesity	0.0011	0.0194	CcSEcCtD
Isoprenaline—PIK3R3—endocrine gland—obesity	0.00106	0.0277	CbGeAlD
Isoprenaline—Cardiac arrest—Phentermine—obesity	0.00105	0.0186	CcSEcCtD
Isoprenaline—PIK3R1—adrenal gland—obesity	0.00104	0.0273	CbGeAlD
Isoprenaline—Sweating—Phendimetrazine—obesity	0.001	0.0177	CcSEcCtD
Isoprenaline—Angina pectoris—Phentermine—obesity	0.000934	0.0165	CcSEcCtD
Isoprenaline—ADRBK1—cardiovascular system—obesity	0.000912	0.0238	CbGeAlD
Isoprenaline—MAPK1—cardiovascular system—obesity	0.000899	0.0235	CbGeAlD
Isoprenaline—Flushing—Phendimetrazine—obesity	0.000871	0.0154	CcSEcCtD
Isoprenaline—Tremor—Methamphetamine—obesity	0.000871	0.0154	CcSEcCtD
Isoprenaline—Tremor—Benzphetamine—obesity	0.00084	0.0148	CcSEcCtD
Isoprenaline—ADRB3—adipose tissue—obesity	0.000823	0.0215	CbGeAlD
Isoprenaline—Palpitations—Methamphetamine—obesity	0.000821	0.0145	CcSEcCtD
Isoprenaline—PIK3R1—liver—obesity	0.000815	0.0213	CbGeAlD
Isoprenaline—ADRBK1—adipose tissue—obesity	0.000804	0.021	CbGeAlD
Isoprenaline—MAPK1—adipose tissue—obesity	0.000793	0.0207	CbGeAlD
Isoprenaline—Palpitations—Benzphetamine—obesity	0.000792	0.014	CcSEcCtD
Isoprenaline—Vision blurred—Phendimetrazine—obesity	0.00077	0.0136	CcSEcCtD
Isoprenaline—Tremor—Phendimetrazine—obesity	0.000765	0.0135	CcSEcCtD
Isoprenaline—ADRBK1—digestive system—obesity	0.000757	0.0198	CbGeAlD
Isoprenaline—MAPK1—digestive system—obesity	0.000746	0.0195	CbGeAlD
Isoprenaline—Flushing—Phenylpropanolamine—obesity	0.000744	0.0131	CcSEcCtD
Isoprenaline—Tachycardia—Methamphetamine—obesity	0.00074	0.0131	CcSEcCtD
Isoprenaline—Palpitations—Phendimetrazine—obesity	0.000722	0.0127	CcSEcCtD
Isoprenaline—ADRBK1—adrenal gland—obesity	0.000722	0.0189	CbGeAlD
Isoprenaline—Arrhythmia—Phenylpropanolamine—obesity	0.000716	0.0126	CcSEcCtD
Isoprenaline—Tachycardia—Benzphetamine—obesity	0.000714	0.0126	CcSEcCtD
Isoprenaline—MAPK1—adrenal gland—obesity	0.000711	0.0186	CbGeAlD
Isoprenaline—Pallor—Bupropion—obesity	0.00071	0.0125	CcSEcCtD
Isoprenaline—Hyperhidrosis—Benzphetamine—obesity	0.000707	0.0125	CcSEcCtD
Isoprenaline—Insomnia—Methamphetamine—obesity	0.000686	0.0121	CcSEcCtD
Isoprenaline—Tension—Phenylpropanolamine—obesity	0.000685	0.0121	CcSEcCtD
Isoprenaline—Nervousness—Phenylpropanolamine—obesity	0.000678	0.012	CcSEcCtD
Isoprenaline—Insomnia—Benzphetamine—obesity	0.000662	0.0117	CcSEcCtD
Isoprenaline—Vision blurred—Phenylpropanolamine—obesity	0.000658	0.0116	CcSEcCtD
Isoprenaline—Tension—Phentermine—obesity	0.000655	0.0116	CcSEcCtD
Isoprenaline—Tremor—Phenylpropanolamine—obesity	0.000654	0.0115	CcSEcCtD
Isoprenaline—Tachycardia—Phendimetrazine—obesity	0.000651	0.0115	CcSEcCtD
Isoprenaline—Nervousness—Phentermine—obesity	0.000649	0.0114	CcSEcCtD
Isoprenaline—Hyperhidrosis—Phendimetrazine—obesity	0.000644	0.0114	CcSEcCtD
Isoprenaline—ADRBK1—endocrine gland—obesity	0.000626	0.0164	CbGeAlD
Isoprenaline—Tremor—Phentermine—obesity	0.000626	0.011	CcSEcCtD
Isoprenaline—MAPK1—endocrine gland—obesity	0.000617	0.0161	CbGeAlD
Isoprenaline—Insomnia—Phendimetrazine—obesity	0.000603	0.0106	CcSEcCtD
Isoprenaline—Arrhythmia—Diethylpropion—obesity	0.000596	0.0105	CcSEcCtD
Isoprenaline—Palpitations—Phentermine—obesity	0.00059	0.0104	CcSEcCtD
Isoprenaline—Hypertension—Phentermine—obesity	0.000577	0.0102	CcSEcCtD
Isoprenaline—Tension—Diethylpropion—obesity	0.00057	0.0101	CcSEcCtD
Isoprenaline—Nervousness—Diethylpropion—obesity	0.000564	0.00996	CcSEcCtD
Isoprenaline—MAPK1—liver—obesity	0.000556	0.0145	CbGeAlD
Isoprenaline—Tachycardia—Phenylpropanolamine—obesity	0.000556	0.00981	CcSEcCtD
Isoprenaline—Vision blurred—Diethylpropion—obesity	0.000547	0.00966	CcSEcCtD
Isoprenaline—Tremor—Diethylpropion—obesity	0.000544	0.0096	CcSEcCtD
Isoprenaline—Hypotension—Phenylpropanolamine—obesity	0.000532	0.00939	CcSEcCtD
Isoprenaline—Tachycardia—Phentermine—obesity	0.000532	0.00939	CcSEcCtD
Isoprenaline—Insomnia—Phenylpropanolamine—obesity	0.000515	0.00909	CcSEcCtD
Isoprenaline—Palpitations—Diethylpropion—obesity	0.000513	0.00906	CcSEcCtD
Isoprenaline—Dyspnoea—Phenylpropanolamine—obesity	0.000508	0.00896	CcSEcCtD
Isoprenaline—Convulsion—Diethylpropion—obesity	0.000503	0.00888	CcSEcCtD
Isoprenaline—Dizziness—Methamphetamine—obesity	0.000502	0.00885	CcSEcCtD
Isoprenaline—Insomnia—Phentermine—obesity	0.000493	0.0087	CcSEcCtD
Isoprenaline—Dizziness—Benzphetamine—obesity	0.000484	0.00853	CcSEcCtD
Isoprenaline—Headache—Methamphetamine—obesity	0.000475	0.00838	CcSEcCtD
Isoprenaline—Cardiac arrest—Sibutramine—obesity	0.000466	0.00823	CcSEcCtD
Isoprenaline—Tachycardia—Diethylpropion—obesity	0.000463	0.00816	CcSEcCtD
Isoprenaline—Hyperhidrosis—Diethylpropion—obesity	0.000458	0.00809	CcSEcCtD
Isoprenaline—Headache—Benzphetamine—obesity	0.000458	0.00809	CcSEcCtD
Isoprenaline—Pallor—Topiramate—obesity	0.000453	0.00799	CcSEcCtD
Isoprenaline—Dizziness—Phendimetrazine—obesity	0.000441	0.00778	CcSEcCtD
Isoprenaline—Tachycardia—Cimetidine—obesity	0.00044	0.00777	CcSEcCtD
Isoprenaline—Nausea—Benzphetamine—obesity	0.000434	0.00767	CcSEcCtD
Isoprenaline—Bronchospasm—Orlistat—obesity	0.000431	0.0076	CcSEcCtD
Isoprenaline—Insomnia—Diethylpropion—obesity	0.000429	0.00757	CcSEcCtD
Isoprenaline—Dyspnoea—Diethylpropion—obesity	0.000423	0.00746	CcSEcCtD
Isoprenaline—Headache—Phendimetrazine—obesity	0.000418	0.00737	CcSEcCtD
Isoprenaline—Angina pectoris—Sibutramine—obesity	0.000413	0.00729	CcSEcCtD
Isoprenaline—Nausea—Phendimetrazine—obesity	0.000396	0.00699	CcSEcCtD
Isoprenaline—Asthenia—Phentermine—obesity	0.000391	0.0069	CcSEcCtD
Isoprenaline—ADRB1—cardiovascular system—obesity	0.000382	0.00997	CbGeAlD
Isoprenaline—Dizziness—Phenylpropanolamine—obesity	0.000377	0.00664	CcSEcCtD
Isoprenaline—Bronchospasm—Bupropion—obesity	0.000363	0.00641	CcSEcCtD
Isoprenaline—Sweating—Sibutramine—obesity	0.000362	0.00639	CcSEcCtD
Isoprenaline—Dizziness—Phentermine—obesity	0.00036	0.00636	CcSEcCtD
Isoprenaline—Headache—Phentermine—obesity	0.000341	0.00602	CcSEcCtD
Isoprenaline—Nausea—Phenylpropanolamine—obesity	0.000338	0.00597	CcSEcCtD
Isoprenaline—ADRB1—adipose tissue—obesity	0.000337	0.00879	CbGeAlD
Isoprenaline—Nausea—Phentermine—obesity	0.000324	0.00571	CcSEcCtD
Isoprenaline—Asthenia—Cimetidine—obesity	0.000324	0.00571	CcSEcCtD
Isoprenaline—CYP1A1—respiratory system—obesity	0.000321	0.0084	CbGeAlD
Isoprenaline—Sweating—Bupropion—obesity	0.000316	0.00557	CcSEcCtD
Isoprenaline—Dizziness—Diethylpropion—obesity	0.000314	0.00553	CcSEcCtD
Isoprenaline—Arrhythmia—Sibutramine—obesity	0.000303	0.00535	CcSEcCtD
Isoprenaline—Dizziness—Cimetidine—obesity	0.000298	0.00526	CcSEcCtD
Isoprenaline—Headache—Diethylpropion—obesity	0.000297	0.00524	CcSEcCtD
Isoprenaline—Tension—Sibutramine—obesity	0.00029	0.00511	CcSEcCtD
Isoprenaline—Vision blurred—Orlistat—obesity	0.000288	0.00507	CcSEcCtD
Isoprenaline—Nervousness—Sibutramine—obesity	0.000287	0.00506	CcSEcCtD
Isoprenaline—Headache—Cimetidine—obesity	0.000283	0.00499	CcSEcCtD
Isoprenaline—Nausea—Diethylpropion—obesity	0.000282	0.00497	CcSEcCtD
Isoprenaline—Vision blurred—Sibutramine—obesity	0.000278	0.00491	CcSEcCtD
Isoprenaline—Tremor—Sibutramine—obesity	0.000277	0.00488	CcSEcCtD
Isoprenaline—Flushing—Bupropion—obesity	0.000274	0.00484	CcSEcCtD
Isoprenaline—Vertigo—Orlistat—obesity	0.000274	0.00484	CcSEcCtD
Isoprenaline—Palpitations—Orlistat—obesity	0.00027	0.00476	CcSEcCtD
Isoprenaline—Nausea—Cimetidine—obesity	0.000268	0.00473	CcSEcCtD
Isoprenaline—Vertigo—Sibutramine—obesity	0.000265	0.00468	CcSEcCtD
Isoprenaline—Convulsion—Orlistat—obesity	0.000264	0.00467	CcSEcCtD
Isoprenaline—Arrhythmia—Bupropion—obesity	0.000264	0.00466	CcSEcCtD
Isoprenaline—ADRB1—endocrine gland—obesity	0.000262	0.00684	CbGeAlD
Isoprenaline—Palpitations—Sibutramine—obesity	0.000261	0.00461	CcSEcCtD
Isoprenaline—Convulsion—Sibutramine—obesity	0.000256	0.00451	CcSEcCtD
Isoprenaline—Hypertension—Sibutramine—obesity	0.000255	0.0045	CcSEcCtD
Isoprenaline—Tension—Bupropion—obesity	0.000253	0.00446	CcSEcCtD
Isoprenaline—Nervousness—Bupropion—obesity	0.00025	0.00441	CcSEcCtD
Isoprenaline—Vision blurred—Bupropion—obesity	0.000243	0.00428	CcSEcCtD
Isoprenaline—Tremor—Bupropion—obesity	0.000241	0.00426	CcSEcCtD
Isoprenaline—Hyperhidrosis—Orlistat—obesity	0.000241	0.00425	CcSEcCtD
Isoprenaline—Tachycardia—Sibutramine—obesity	0.000235	0.00415	CcSEcCtD
Isoprenaline—Hyperhidrosis—Sibutramine—obesity	0.000233	0.00411	CcSEcCtD
Isoprenaline—Vertigo—Bupropion—obesity	0.000231	0.00408	CcSEcCtD
Isoprenaline—Angina pectoris—Topiramate—obesity	0.000229	0.00405	CcSEcCtD
Isoprenaline—Palpitations—Bupropion—obesity	0.000228	0.00401	CcSEcCtD
Isoprenaline—Insomnia—Orlistat—obesity	0.000225	0.00397	CcSEcCtD
Isoprenaline—Hypotension—Sibutramine—obesity	0.000225	0.00397	CcSEcCtD
Isoprenaline—Convulsion—Bupropion—obesity	0.000223	0.00394	CcSEcCtD
Isoprenaline—Hypertension—Bupropion—obesity	0.000222	0.00392	CcSEcCtD
Isoprenaline—Insomnia—Sibutramine—obesity	0.000218	0.00385	CcSEcCtD
Isoprenaline—CYP1A1—adipose tissue—obesity	0.000217	0.00567	CbGeAlD
Isoprenaline—Dyspnoea—Sibutramine—obesity	0.000215	0.00379	CcSEcCtD
Isoprenaline—Tachycardia—Bupropion—obesity	0.000205	0.00362	CcSEcCtD
Isoprenaline—CYP1A1—digestive system—obesity	0.000204	0.00534	CbGeAlD
Isoprenaline—Hyperhidrosis—Bupropion—obesity	0.000203	0.00358	CcSEcCtD
Isoprenaline—Fenoterol—ADRB3—obesity	0.000197	0.0534	CrCbGaD
Isoprenaline—Hypotension—Bupropion—obesity	0.000196	0.00346	CcSEcCtD
Isoprenaline—Insomnia—Bupropion—obesity	0.00019	0.00335	CcSEcCtD
Isoprenaline—Dyspnoea—Bupropion—obesity	0.000187	0.00331	CcSEcCtD
Isoprenaline—Arbutamine—ADRB3—obesity	0.000184	0.05	CrCbGaD
Isoprenaline—Asthenia—Orlistat—obesity	0.000179	0.00315	CcSEcCtD
Isoprenaline—Flushing—Topiramate—obesity	0.000175	0.00309	CcSEcCtD
Isoprenaline—Asthenia—Sibutramine—obesity	0.000173	0.00305	CcSEcCtD
Isoprenaline—CYP1A1—endocrine gland—obesity	0.000169	0.00441	CbGeAlD
Isoprenaline—Dizziness—Orlistat—obesity	0.000165	0.00291	CcSEcCtD
Isoprenaline—Tension—Topiramate—obesity	0.000161	0.00284	CcSEcCtD
Isoprenaline—Dizziness—Sibutramine—obesity	0.000159	0.00281	CcSEcCtD
Isoprenaline—Nervousness—Topiramate—obesity	0.000159	0.00281	CcSEcCtD
Isoprenaline—Headache—Orlistat—obesity	0.000156	0.00275	CcSEcCtD
Isoprenaline—Vision blurred—Topiramate—obesity	0.000155	0.00273	CcSEcCtD
Isoprenaline—Tremor—Topiramate—obesity	0.000154	0.00271	CcSEcCtD
Isoprenaline—CYP1A1—liver—obesity	0.000152	0.00398	CbGeAlD
Isoprenaline—Headache—Sibutramine—obesity	0.000151	0.00266	CcSEcCtD
Isoprenaline—Asthenia—Bupropion—obesity	0.000151	0.00266	CcSEcCtD
Isoprenaline—Nausea—Orlistat—obesity	0.000148	0.00261	CcSEcCtD
Isoprenaline—Vertigo—Topiramate—obesity	0.000147	0.0026	CcSEcCtD
Isoprenaline—Palpitations—Topiramate—obesity	0.000145	0.00256	CcSEcCtD
Isoprenaline—Nausea—Sibutramine—obesity	0.000143	0.00253	CcSEcCtD
Isoprenaline—Convulsion—Topiramate—obesity	0.000142	0.00251	CcSEcCtD
Isoprenaline—Hypertension—Topiramate—obesity	0.000142	0.0025	CcSEcCtD
Isoprenaline—Orciprenaline—ADRB2—obesity	0.000139	0.0378	CrCbGaD
Isoprenaline—Dizziness—Bupropion—obesity	0.000139	0.00245	CcSEcCtD
Isoprenaline—Headache—Bupropion—obesity	0.000132	0.00232	CcSEcCtD
Isoprenaline—Tachycardia—Topiramate—obesity	0.000131	0.00231	CcSEcCtD
Isoprenaline—Labetalol—ADRB3—obesity	0.00013	0.0354	CrCbGaD
Isoprenaline—Hyperhidrosis—Topiramate—obesity	0.000129	0.00228	CcSEcCtD
Isoprenaline—Pindolol—ADRB3—obesity	0.000125	0.034	CrCbGaD
Isoprenaline—Hypotension—Topiramate—obesity	0.000125	0.00221	CcSEcCtD
Isoprenaline—Nausea—Bupropion—obesity	0.000125	0.0022	CcSEcCtD
Isoprenaline—Insomnia—Topiramate—obesity	0.000121	0.00214	CcSEcCtD
Isoprenaline—Methyldopa—COMT—obesity	0.00012	0.0326	CrCbGaD
Isoprenaline—Dyspnoea—Topiramate—obesity	0.000119	0.00211	CcSEcCtD
Isoprenaline—Terbutaline—BCHE—obesity	0.000106	0.0289	CrCbGaD
Isoprenaline—Droxidopa—ADRB3—obesity	0.000106	0.0287	CrCbGaD
Isoprenaline—Isoetarine—ADRB1—obesity	0.000105	0.0284	CrCbGaD
Isoprenaline—Sotalol—ADRB1—obesity	0.000101	0.0274	CrCbGaD
Isoprenaline—Asthenia—Topiramate—obesity	9.6e-05	0.00169	CcSEcCtD
Isoprenaline—Terbutaline—ADRB2—obesity	9.13e-05	0.0248	CrCbGaD
Isoprenaline—Norepinephrine—ADRB3—obesity	8.89e-05	0.0242	CrCbGaD
Isoprenaline—Fenoterol—ADRB1—obesity	8.89e-05	0.0241	CrCbGaD
Isoprenaline—Dizziness—Topiramate—obesity	8.85e-05	0.00156	CcSEcCtD
Isoprenaline—Isoetarine—ADRB2—obesity	8.79e-05	0.0239	CrCbGaD
Isoprenaline—Masoprocol—CYP19A1—obesity	8.51e-05	0.0231	CrCbGaD
Isoprenaline—Sotalol—ADRB2—obesity	8.49e-05	0.0231	CrCbGaD
Isoprenaline—Headache—Topiramate—obesity	8.39e-05	0.00148	CcSEcCtD
Isoprenaline—Arbutamine—ADRB1—obesity	8.31e-05	0.0226	CrCbGaD
Isoprenaline—Arformoterol—ADRB1—obesity	8.07e-05	0.0219	CrCbGaD
Isoprenaline—Formoterol—ADRB1—obesity	8.07e-05	0.0219	CrCbGaD
Isoprenaline—Salbutamol—ADRB1—obesity	8.07e-05	0.0219	CrCbGaD
Isoprenaline—Epinephrine—ADRB3—obesity	8.07e-05	0.0219	CrCbGaD
Isoprenaline—Nausea—Topiramate—obesity	7.95e-05	0.0014	CcSEcCtD
Isoprenaline—Fenoterol—ADRB2—obesity	7.47e-05	0.0203	CrCbGaD
Isoprenaline—Arbutamine—ADRB2—obesity	6.99e-05	0.019	CrCbGaD
Isoprenaline—Salbutamol—ADRB2—obesity	6.79e-05	0.0184	CrCbGaD
Isoprenaline—Formoterol—ADRB2—obesity	6.79e-05	0.0184	CrCbGaD
Isoprenaline—Arformoterol—ADRB2—obesity	6.79e-05	0.0184	CrCbGaD
Isoprenaline—Pindolol—HTR1B—obesity	6.4e-05	0.0174	CrCbGaD
Isoprenaline—Labetalol—ADRB1—obesity	5.9e-05	0.016	CrCbGaD
Isoprenaline—Dopamine—COMT—obesity	5.87e-05	0.0159	CrCbGaD
Isoprenaline—Pindolol—ADRB1—obesity	5.66e-05	0.0154	CrCbGaD
Isoprenaline—Norepinephrine—SLC22A1—obesity	5.3e-05	0.0144	CrCbGaD
Isoprenaline—L-DOPA—DRD4—obesity	5.12e-05	0.0139	CrCbGaD
Isoprenaline—Labetalol—ADRB2—obesity	4.96e-05	0.0135	CrCbGaD
Isoprenaline—Dopamine—SLC22A1—obesity	4.92e-05	0.0134	CrCbGaD
Isoprenaline—Epinephrine—SLC22A1—obesity	4.81e-05	0.0131	CrCbGaD
Isoprenaline—Droxidopa—ADRB1—obesity	4.77e-05	0.013	CrCbGaD
Isoprenaline—Pindolol—ADRB2—obesity	4.76e-05	0.0129	CrCbGaD
Isoprenaline—Dopamine—DRD4—obesity	4.76e-05	0.0129	CrCbGaD
Isoprenaline—L-DOPA—DRD1—obesity	4.33e-05	0.0118	CrCbGaD
Isoprenaline—Dopamine—DRD1—obesity	4.03e-05	0.0109	CrCbGaD
Isoprenaline—Norepinephrine—ADRB1—obesity	4.02e-05	0.0109	CrCbGaD
Isoprenaline—Droxidopa—ADRB2—obesity	4.02e-05	0.0109	CrCbGaD
Isoprenaline—Dopamine—ADRB1—obesity	3.74e-05	0.0102	CrCbGaD
Isoprenaline—Epinephrine—ADRB1—obesity	3.65e-05	0.00991	CrCbGaD
Isoprenaline—Epinephrine—TNF—obesity	3.46e-05	0.0094	CrCbGaD
Isoprenaline—Norepinephrine—ADRB2—obesity	3.38e-05	0.00918	CrCbGaD
Isoprenaline—Epinephrine—ADRB2—obesity	3.07e-05	0.00833	CrCbGaD
Isoprenaline—L-DOPA—DRD2—obesity	3.05e-05	0.00829	CrCbGaD
Isoprenaline—Norepinephrine—DRD2—obesity	3.05e-05	0.00829	CrCbGaD
Isoprenaline—Dopamine—SLC6A4—obesity	2.85e-05	0.00775	CrCbGaD
Isoprenaline—Dopamine—DRD2—obesity	2.84e-05	0.00771	CrCbGaD
Isoprenaline—ADRBK1—Signaling Pathways—MAPK8—obesity	1.16e-06	9.03e-06	CbGpPWpGaD
Isoprenaline—PIK3R1—Disease—MYC—obesity	1.16e-06	9.01e-06	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling by GPCR—AKT1—obesity	1.16e-06	9e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—APOB—obesity	1.16e-06	8.99e-06	CbGpPWpGaD
Isoprenaline—PIK3R1—Disease—TGFB1—obesity	1.16e-06	8.99e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—CCL5—obesity	1.16e-06	8.98e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Developmental Biology—AKT1—obesity	1.15e-06	8.94e-06	CbGpPWpGaD
Isoprenaline—ADRBK1—Immune System—IL6—obesity	1.15e-06	8.92e-06	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CB—obesity	1.15e-06	8.89e-06	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling by GPCR—PIK3CA—obesity	1.14e-06	8.85e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—IRS2—obesity	1.14e-06	8.82e-06	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—obesity	1.14e-06	8.81e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—AGT—obesity	1.14e-06	8.81e-06	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—MTOR—obesity	1.13e-06	8.78e-06	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—PIK3CB—obesity	1.13e-06	8.78e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—CCL5—obesity	1.13e-06	8.78e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—LPL—obesity	1.13e-06	8.78e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Hemostasis—AKT1—obesity	1.13e-06	8.77e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—FOXO1—obesity	1.12e-06	8.72e-06	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—GCG—obesity	1.12e-06	8.71e-06	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—SLC2A4—obesity	1.12e-06	8.71e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—RPS6KB1—obesity	1.12e-06	8.7e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—APOE—obesity	1.11e-06	8.63e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—LEP—obesity	1.11e-06	8.63e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling by GPCR—PIK3CB—obesity	1.11e-06	8.61e-06	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—CYCS—obesity	1.11e-06	8.59e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—LPL—obesity	1.11e-06	8.59e-06	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—PIK3CB—obesity	1.11e-06	8.57e-06	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—MTOR—obesity	1.11e-06	8.57e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Innate Immune System—IL6—obesity	1.1e-06	8.56e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—CAV1—obesity	1.1e-06	8.55e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—APOA1—obesity	1.1e-06	8.53e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Disease—MTOR—obesity	1.1e-06	8.53e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Disease—PIK3CB—obesity	1.1e-06	8.53e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—FOXO1—obesity	1.1e-06	8.53e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—IL1B—obesity	1.1e-06	8.51e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—RPS6KB1—obesity	1.1e-06	8.51e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Disease—PTGS2—obesity	1.09e-06	8.45e-06	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—GGT1—obesity	1.09e-06	8.43e-06	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—GOT1—obesity	1.09e-06	8.43e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling by GPCR—PIK3CB—obesity	1.09e-06	8.43e-06	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—STAT3—obesity	1.08e-06	8.38e-06	CbGpPWpGaD
Isoprenaline—PIK3R2—Disease—IL6—obesity	1.08e-06	8.36e-06	CbGpPWpGaD
Isoprenaline—PIK3R2—Immune System—AKT1—obesity	1.08e-06	8.35e-06	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—NCOA1—obesity	1.07e-06	8.31e-06	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling Pathways—PIK3CA—obesity	1.07e-06	8.29e-06	CbGpPWpGaD
Isoprenaline—PIK3R1—Immune System—PIK3CA—obesity	1.07e-06	8.28e-06	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—STAT3—obesity	1.06e-06	8.25e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—ESR1—obesity	1.06e-06	8.24e-06	CbGpPWpGaD
Isoprenaline—ADRBK1—Disease—IL6—obesity	1.06e-06	8.23e-06	CbGpPWpGaD
Isoprenaline—ADRBK1—Immune System—AKT1—obesity	1.06e-06	8.22e-06	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—STK11—obesity	1.06e-06	8.19e-06	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—CYP19A1—obesity	1.06e-06	8.19e-06	CbGpPWpGaD
Isoprenaline—PIK3R1—GPCR downstream signaling—AKT1—obesity	1.05e-06	8.15e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—F2—obesity	1.05e-06	8.14e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—PRKCB—obesity	1.05e-06	8.14e-06	CbGpPWpGaD
Isoprenaline—PIK3R3—Metabolism—AKT1—obesity	1.05e-06	8.1e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—PRKCD—obesity	1.04e-06	8.09e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—BAD—obesity	1.04e-06	8.05e-06	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling by GPCR—IL6—obesity	1.04e-06	8.03e-06	CbGpPWpGaD
Isoprenaline—ADRB3—GPCR downstream signaling—AKT1—obesity	1.03e-06	7.96e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—HTR2A—obesity	1.02e-06	7.91e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—PRKCD—obesity	1.02e-06	7.91e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—C3—obesity	1.02e-06	7.9e-06	CbGpPWpGaD
Isoprenaline—PIK3R2—Metabolism—PIK3CA—obesity	1.02e-06	7.9e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Innate Immune System—AKT1—obesity	1.02e-06	7.9e-06	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling by GPCR—IL6—obesity	1.01e-06	7.83e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—MAPK8—obesity	1.01e-06	7.81e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—PIK3CG—obesity	1.01e-06	7.79e-06	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—MYC—obesity	1e-06	7.78e-06	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—TGFB1—obesity	1e-06	7.77e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—HTR2A—obesity	9.99e-07	7.74e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—C3—obesity	9.98e-07	7.73e-06	CbGpPWpGaD
Isoprenaline—PIK3R2—Disease—AKT1—obesity	9.95e-07	7.71e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—IRS1—obesity	9.94e-07	7.7e-06	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—MYC—obesity	9.89e-07	7.67e-06	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—TGFB1—obesity	9.87e-07	7.65e-06	CbGpPWpGaD
Isoprenaline—PIK3R1—Disease—PIK3CA—obesity	9.87e-07	7.65e-06	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—MMP9—obesity	9.85e-07	7.63e-06	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—COMT—obesity	9.82e-07	7.61e-06	CbGpPWpGaD
Isoprenaline—ADRBK1—Disease—AKT1—obesity	9.8e-07	7.59e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—IRS2—obesity	9.7e-07	7.52e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—AGT—obesity	9.69e-07	7.51e-06	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—PPARGC1A—obesity	9.68e-07	7.5e-06	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—GNB3—obesity	9.68e-07	7.5e-06	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—HMOX1—obesity	9.64e-07	7.47e-06	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—MMP9—obesity	9.61e-07	7.45e-06	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—MAPK8—obesity	9.58e-07	7.42e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—POMC—obesity	9.57e-07	7.42e-06	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling by GPCR—AKT1—obesity	9.55e-07	7.4e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—INS—obesity	9.52e-07	7.38e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—APOE—obesity	9.49e-07	7.36e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—LEP—obesity	9.49e-07	7.36e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—IRS2—obesity	9.49e-07	7.36e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—AGT—obesity	9.48e-07	7.35e-06	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling Pathways—IL6—obesity	9.47e-07	7.34e-06	CbGpPWpGaD
Isoprenaline—PIK3R1—Immune System—IL6—obesity	9.46e-07	7.33e-06	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—GNAS—obesity	9.43e-07	7.31e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—CAV1—obesity	9.41e-07	7.29e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—APOA1—obesity	9.38e-07	7.27e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—CCL2—obesity	9.36e-07	7.26e-06	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—MAPK8—obesity	9.35e-07	7.25e-06	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling by GPCR—AKT1—obesity	9.32e-07	7.23e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—LEP—obesity	9.29e-07	7.2e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—APOE—obesity	9.29e-07	7.2e-06	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—APOB—obesity	9.23e-07	7.16e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—STAT3—obesity	9.21e-07	7.14e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—IGF1—obesity	9.2e-07	7.13e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—CAV1—obesity	9.2e-07	7.13e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—AKT2—obesity	9.2e-07	7.13e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—APOA1—obesity	9.18e-07	7.12e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—ESR1—obesity	9.06e-07	7.02e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—PRKCB—obesity	8.95e-07	6.94e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—F2—obesity	8.95e-07	6.94e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—ESR1—obesity	8.87e-07	6.87e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—BAD—obesity	8.85e-07	6.86e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—PIK3CD—obesity	8.84e-07	6.85e-06	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—LPL—obesity	8.82e-07	6.83e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—F2—obesity	8.76e-07	6.79e-06	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—STAT3—obesity	8.76e-07	6.79e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—PRKCB—obesity	8.76e-07	6.79e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—SERPINE1—obesity	8.74e-07	6.77e-06	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling Pathways—AKT1—obesity	8.74e-07	6.77e-06	CbGpPWpGaD
Isoprenaline—PIK3R1—Disease—IL6—obesity	8.74e-07	6.77e-06	CbGpPWpGaD
Isoprenaline—PIK3R1—Immune System—AKT1—obesity	8.73e-07	6.77e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—BAD—obesity	8.65e-07	6.71e-06	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—GPX1—obesity	8.6e-07	6.67e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—PIK3CG—obesity	8.57e-07	6.64e-06	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—STAT3—obesity	8.55e-07	6.63e-06	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—PIK3CA—obesity	8.53e-07	6.61e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—TYK2—obesity	8.5e-07	6.59e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Disease—STAT3—obesity	8.5e-07	6.59e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—IRS1—obesity	8.47e-07	6.56e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—RHOA—obesity	8.43e-07	6.54e-06	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—PIK3CA—obesity	8.4e-07	6.51e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—PIK3CG—obesity	8.38e-07	6.5e-06	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—CD36—obesity	8.38e-07	6.49e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—PIK3R1—obesity	8.35e-07	6.47e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—NOS3—obesity	8.35e-07	6.47e-06	CbGpPWpGaD
Isoprenaline—PIK3R2—Metabolism—AKT1—obesity	8.33e-07	6.46e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—IRS1—obesity	8.28e-07	6.42e-06	CbGpPWpGaD
Isoprenaline—PIK3R1—Metabolism—PIK3CA—obesity	8.26e-07	6.4e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—POMC—obesity	8.16e-07	6.32e-06	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—MYC—obesity	8.14e-07	6.31e-06	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—TGFB1—obesity	8.12e-07	6.29e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—INS—obesity	8.11e-07	6.29e-06	CbGpPWpGaD
Isoprenaline—PIK3R1—Disease—AKT1—obesity	8.06e-07	6.25e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—CCL2—obesity	7.98e-07	6.18e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—POMC—obesity	7.98e-07	6.18e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling by GPCR—PIK3CA—obesity	7.95e-07	6.16e-06	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—MYC—obesity	7.94e-07	6.16e-06	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—MTHFR—obesity	7.94e-07	6.15e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—INS—obesity	7.93e-07	6.15e-06	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—TGFB1—obesity	7.92e-07	6.14e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Disease—MYC—obesity	7.9e-07	6.12e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Disease—TGFB1—obesity	7.88e-07	6.11e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—IGF1—obesity	7.84e-07	6.08e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—AKT2—obesity	7.84e-07	6.08e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—CCL2—obesity	7.81e-07	6.05e-06	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—PPARA—obesity	7.79e-07	6.04e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—MTOR—obesity	7.7e-07	5.97e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—PIK3CB—obesity	7.7e-07	5.97e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—IGF1—obesity	7.67e-07	5.95e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—AKT2—obesity	7.67e-07	5.94e-06	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—IL6—obesity	7.55e-07	5.85e-06	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—AGT—obesity	7.54e-07	5.85e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—PIK3CD—obesity	7.53e-07	5.84e-06	CbGpPWpGaD
Isoprenaline—ADRB1—GPCR downstream signaling—PIK3CA—obesity	7.46e-07	5.78e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—SERPINE1—obesity	7.45e-07	5.77e-06	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—IL6—obesity	7.44e-07	5.76e-06	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—APOE—obesity	7.39e-07	5.73e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—PIK3CD—obesity	7.37e-07	5.71e-06	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—CAV1—obesity	7.32e-07	5.67e-06	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—APOA1—obesity	7.3e-07	5.66e-06	CbGpPWpGaD
Isoprenaline—ADRB2—GPCR downstream signaling—PIK3CA—obesity	7.3e-07	5.66e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—SERPINE1—obesity	7.29e-07	5.65e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—PIK3CA—obesity	7.26e-07	5.63e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—TYK2—obesity	7.25e-07	5.62e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—RHOA—obesity	7.19e-07	5.57e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—PIK3R1—obesity	7.11e-07	5.51e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—NOS3—obesity	7.11e-07	5.51e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—TYK2—obesity	7.09e-07	5.49e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling by GPCR—IL6—obesity	7.04e-07	5.46e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—RHOA—obesity	7.03e-07	5.45e-06	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—obesity	6.99e-07	5.42e-06	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—AKT1—obesity	6.97e-07	5.4e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—PIK3R1—obesity	6.96e-07	5.39e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—NOS3—obesity	6.96e-07	5.39e-06	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—PIK3CA—obesity	6.91e-07	5.35e-06	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—AKT1—obesity	6.86e-07	5.32e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling by GPCR—PIK3CA—obesity	6.77e-07	5.25e-06	CbGpPWpGaD
Isoprenaline—PIK3R1—Metabolism—AKT1—obesity	6.75e-07	5.23e-06	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—PIK3CA—obesity	6.74e-07	5.23e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Disease—PIK3CA—obesity	6.71e-07	5.2e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—MMP9—obesity	6.7e-07	5.19e-06	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—PIK3CG—obesity	6.67e-07	5.17e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling by GPCR—PIK3CA—obesity	6.63e-07	5.14e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—MTOR—obesity	6.57e-07	5.09e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—PIK3CB—obesity	6.57e-07	5.09e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—MAPK8—obesity	6.51e-07	5.05e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling by GPCR—AKT1—obesity	6.49e-07	5.03e-06	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—PPARG—obesity	6.44e-07	4.99e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—IL6—obesity	6.43e-07	4.98e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—PIK3CB—obesity	6.42e-07	4.98e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—MTOR—obesity	6.42e-07	4.98e-06	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—POMC—obesity	6.35e-07	4.92e-06	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—INS—obesity	6.31e-07	4.89e-06	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—IL6—obesity	6.12e-07	4.74e-06	CbGpPWpGaD
Isoprenaline—ADRB1—GPCR downstream signaling—AKT1—obesity	6.09e-07	4.72e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling by GPCR—IL6—obesity	6e-07	4.65e-06	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—IL6—obesity	5.97e-07	4.63e-06	CbGpPWpGaD
Isoprenaline—ADRB2—GPCR downstream signaling—AKT1—obesity	5.96e-07	4.62e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—STAT3—obesity	5.95e-07	4.61e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Disease—IL6—obesity	5.94e-07	4.6e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—AKT1—obesity	5.93e-07	4.6e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling by GPCR—IL6—obesity	5.87e-07	4.55e-06	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—PIK3CD—obesity	5.86e-07	4.54e-06	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—ALB—obesity	5.79e-07	4.49e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—MMP9—obesity	5.71e-07	4.42e-06	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—AKT1—obesity	5.64e-07	4.37e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—MMP9—obesity	5.58e-07	4.33e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—MAPK8—obesity	5.55e-07	4.3e-06	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—PIK3R1—obesity	5.54e-07	4.29e-06	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—NOS3—obesity	5.54e-07	4.29e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling by GPCR—AKT1—obesity	5.53e-07	4.29e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—MYC—obesity	5.53e-07	4.29e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—TGFB1—obesity	5.52e-07	4.28e-06	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—AKT1—obesity	5.51e-07	4.27e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Disease—AKT1—obesity	5.48e-07	4.25e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—MAPK8—obesity	5.43e-07	4.21e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling by GPCR—AKT1—obesity	5.41e-07	4.2e-06	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—PIK3CB—obesity	5.11e-07	3.96e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—STAT3—obesity	5.07e-07	3.93e-06	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—PTGS2—obesity	5.06e-07	3.92e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—STAT3—obesity	4.96e-07	3.85e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—MYC—obesity	4.71e-07	3.65e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—TGFB1—obesity	4.7e-07	3.65e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—PIK3CA—obesity	4.7e-07	3.64e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—MYC—obesity	4.61e-07	3.57e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—TGFB1—obesity	4.6e-07	3.57e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—IL6—obesity	4.16e-07	3.22e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—PIK3CA—obesity	4e-07	3.1e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—PIK3CA—obesity	3.91e-07	3.03e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—AKT1—obesity	3.84e-07	2.97e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—IL6—obesity	3.54e-07	2.75e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—IL6—obesity	3.47e-07	2.69e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—AKT1—obesity	3.27e-07	2.53e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—AKT1—obesity	3.2e-07	2.48e-06	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—PIK3CA—obesity	3.12e-07	2.41e-06	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—AKT1—obesity	2.54e-07	1.97e-06	CbGpPWpGaD
